SEC 13F Intelligence

Managers / Q1 2021 · view latest →

Worth Venture Partners, LLC

CIK 0001696778 · 2 EXECUTIVE DRIVE, SUITE 515, FORT LEE, NJ, 07024 · 2125589017

Reported Value
$206M
Q1 2021
Positions
111
Filings on Record
30
2019–present window
Filed
May 17, 2021
original filing

Summary

Worth Venture Partners, LLC reported $206M in U.S.-listed holdings across 111 positions for Q1 2021.

Its largest position, Wayfair, represents 5.7% of the portfolio.

Compared with Q4 2020, the fund opened 53 new positions and exited 43.

Portfolio Metrics

Turnover
+25.4%
vs prior filed quarter
Top-10 Concentration
+40.3%
share of reported value
Largest Position
+5.7%
Wayfair
New / Exited
53 / 43
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $132MQ4 ’18Q1 ’19: $180MQ2 ’19: $181MQ3 ’19: $175MQ4 ’19: $204MQ4 ’19Q1 ’20: $162MQ2 ’20: $204MQ3 ’20: $122MQ4 ’20: $126MQ4 ’20Q1 ’21: $206MQ2 ’21: $269MQ3 ’21: $222MQ4 ’21: $202MQ4 ’21Q1 ’22: $217MQ2 ’22: $170MQ3 ’22: $163MQ4 ’22: $169MQ4 ’22Q1 ’23: $205MQ2 ’23: $184MQ3 ’23: $169MQ4 ’23: $185MQ4 ’23Q1 ’24: $15MQ2 ’24: $13MQ3 ’24: $14MQ4 ’24: $10MQ4 ’24Q1 ’25: $53MQ2 ’25: $65MQ3 ’25: $34MQ4 ’25: $14MQ4 ’25Q1 ’26: $32Mfilingsflow.com

Portfolio Composition

By security type
US DOMESTIC: 47.4%Common Stock: 33.6%Other: 10.7%ADR: 3.8%GLOBAL: 3.4%Other: 1.1%
  • US DOMESTIC · 47.4% · $98M
  • Common Stock · 33.6% · $69M
  • Other · 10.7% · $22M
  • ADR · 3.8% · $8M
  • GLOBAL · 3.4% · $7M
  • Other · 1.1% · $2M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2020 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
SOUTHWEST AIRLS CONEW+3.56M3.56M+$6M$6M
TALEND S ANEW+65.8K65.8K+$4M$4M
AMERICAN AIRLS GROUP INCNEW+2.05M2.05M+$4M$4M
SAREPTA THERAPEUTICS INCNEW+2.58M2.58M+$3M$3M
ALLSCRIPTS HEALTHCARE SOLUTNNEW+2.49M2.49M+$3M$3M
ON SEMICONDUCTOR CORPNEW+1.57M1.57M+$3M$3M
DZSIQDZS INCNEW+170.1K170.1K+$3M$3M
RMNIRIMINI STR INC DELNEW+277.6K277.6K+$2M$2M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2021

48 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1NUANCE COMMUNICATIONS INCNOTE 1.250% 4/0 · DBCV 1.000%12/15.98%$12M5.95M
2WAYFAIR INCNOTE 1.000% 8/15.73%$12M5.31M
3WORKDAY INCNOTE 0.250%10/05.59%$12M6.67M
4UNITED STATES STL CORP NEWNOTE 5.000%11/05.35%$11M5.07M
5SPIRIT AIRLS INCNOTE 4.750% 5/15.08%$10M3.40M
6WORLD WRESTLING ENTMT INCNOTE 3.375%12/13.72%$8M3.39M
7COHUCOHU INChistory →COM3.36%$7M165.5K
8SOUTHWEST AIRLS CONOTE 1.250% 5/02.97%$6M3.56M
9LIBERTY MEDIA CORP DELNOTE 1.375%10/12.56%$5M4.09M
10PALO ALTO NETWORKS INCNOTE 0.750% 7/02.46%$5M3.83M
11AVNWAVIAT NETWORKS INChistory →COM NEW2.39%$5M69.5K
12EMKREUREMCORE CORPhistory →COM NEW2.10%$4M793.7K
13TALEND S AADS2.03%$4M65.8K
14O2MICRO INTERNATIONAL LIMITESPONS ADR1.76%$4M465.2K
15AMERICAN AIRLS GROUP INCNOTE 6.500% 7/01.71%$4M2.05M
16SAREPTA THERAPEUTICS INCDBCV 1.500%11/11.65%$3M2.58M
17ALLSCRIPTS HEALTHCARE SOLUTNNOTE 0.875% 1/01.60%$3M2.49M
18THERATECHNOLGIES INCCOM1.60%$3M851.4K
19ON SEMICONDUCTOR CORPNOTE 1.625%10/11.59%$3M1.57M
20ASPNASPEN AEROGELS INChistory →COM1.45%$3M146.7K
21DZSIQDZS INChistory →COM1.28%$3M170.1K
22AVYAUSDAVAYA HLDGS CORPhistory →COM1.25%$3M92.3K
23ADMSEURADAMAS PHARMACEUTICALS INChistory →COM1.25%$3M538.4K
24GUESS INCNOTE 2.000% 4/11.25%$3M2.23M
25RMNIRIMINI STR INC DELhistory →COM1.21%$2M277.6K
26LUMENTUM HLDGS INCNOTE 0.250% 3/11.19%$2M1.51M
27ILLUMINA INCNOTE 0.500% 6/11.11%$2M1.51M
28PBYIPUMA BIOTECHNOLOGY INChistory →COM1.07%$2M226.8K
29EDAEDAP TMS S Ahistory →SPONSORED ADR1.04%$2M254.8K
30SILICOM LTDORD0.99%$2M45.4K
31NUVVE HOLDING ORDCOM0.94%$2M202.7K
32GRTXGALERA THERAPEUTICS INCCOM0.92%$2M214.2K
33TWITTER INCNOTE 1.000% 9/10.85%$2M1.69M
34BWAYBRAINSWAY LTDSPONSORED ADS0.78%$2M178.6K
35CDLXEURCARDLYTICS INCCOM0.75%$2M14.1K
36STRONGBRIDGE BIOPHARMA PLCSHS USD0.74%$2M550.2K
37ALLOT LTDSHS0.71%$1M92.3K
38LPZBLIGHTPATH TECHNOLOGIES INCCOM CL A0.71%$1M469.9K
39AIRGAIRGAIN INCCOM0.70%$1M68.2K
40BCOVUSDBRIGHTCOVE INCCOM0.69%$1M71.0K
41SCPHSCPHARMACEUTICALS INCCOM0.69%$1M214.1K
42ALNAEURALLENA PHARMACEUTICALSCOM0.66%$1M980.2K
43CVNACARVANA COCL A0.66%$1M5.2K
44PRTKEURPARATEK PHARMACEUTICALS INCCOM0.65%$1M191.1K
45OMFONEMAIN HLDGS INCCOM0.64%$1M24.4K
46HOMEAT HOME GROUP INCCOM0.61%$1M43.9K
47INFIQINFINITY PHARMACEUTICALS INCCOM0.61%$1M387.1K
48ALIMERA SCIENCES INCCOM NEW0.59%$1M127.3K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$32M55May 14, 202613F-HRchanges · EDGAR ↗
Q4 2025$14M53Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$34M64Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$65M42Aug 13, 202513F-HRchanges · EDGAR ↗
Q1 2025$53M36May 14, 202513F-HRchanges · EDGAR ↗
Q4 2024$10M34Feb 12, 202513F-HRchanges · EDGAR ↗
Q3 2024$14M49Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$13M56Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$15M63May 13, 202413F-HRchanges · EDGAR ↗
Q4 2023$185M130Feb 9, 202413F-HRchanges · EDGAR ↗
Q3 2023$169M163Nov 15, 202313F-HRchanges · EDGAR ↗
Q2 2023$184M173Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$205M194May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$169M183Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$163M183Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$170M150Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$217M148May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$202M130Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$222M130Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$269M115Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$206M111May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$126M101Feb 17, 202113F-HRchanges · EDGAR ↗
Q3 2020$122M220Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$204M220Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$162M198May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$204M178Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$175M193Nov 12, 201913F-HRchanges · EDGAR ↗
Q2 2019$181M197Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$180M204May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$132M209Feb 15, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 2 additional managers.

  • DLD Asset Management, LP028-17749
  • AIGH Capital Management LLC028-20823

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.